Income Statement
publishThe Stocklytics Income Statement Screener empowers investors to focus on companies with strong financial fundamentals. Whether you’re interested in growth, profitability, or overall revenue strength, this tool helps you make informed decisions.
| name | arrow_downwardRevenue | Price | $ Change | % Change | Revenue Growth % | Gross Profit | Operating Income | Net Income | EBITDA | EPS Diluted | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FRPTFreshpet | $975.17M | $84.50 | -$0.50 | arrow_drop_down0.58% | arrow_drop_up27.15% | $395.95M | $37.99M | $46.92M | $133.40M | 0.93 | |||
DAC DACDanaos | $973.58M | $84.44 | $0.83 | arrow_drop_up0.99% | - | $643.70M | $580.66M | $576.29M | $675.74M | 28.89 | |||
AGNCLAGNC Investment Corp. - Depositary Shares Each Representing a 1/1,000th Interest in a Share of 7.75% Series G Fixed-Rate Reset Cumulative Redeemable Preferred S | $973.00M | $25.01 | -$0.11 | arrow_drop_down0.43% | - | _ | -$184.00M | $863.00M | $0.00 | 0.00 | |||
MNDYmonday.com Ltd. | $971.99M | $289.38 | -$0.33 | arrow_drop_down0.11% | arrow_drop_up33.20% | $868.30M | -$21.03M | $32.37M | $11.98M | 0.62 | |||
JBIJanus International Group | $963.80M | $8.03 | -$0.18 | arrow_drop_down2.24% | - | $397.80M | $146.60M | $70.40M | $202.70M | 0.49 | |||
CAVACAVA Group, Inc. Common Stock | $963.71M | $83.73 | -$0.69 | arrow_drop_down0.81% | arrow_drop_up32.25% | $646.37M | $43.11M | $130.31M | $139.13M | 1.10 | |||
MRTNMarten Transport Ltd | $963.70M | $12.97 | -$0.01 | arrow_drop_down0.11% | - | $452.83M | $33.22M | $26.92M | $134.93M | 0.33 | |||
CFLTConfluent | $963.64M | $21.84 | -$0.08 | arrow_drop_down0.36% | arrow_drop_up24.02% | $706.17M | -$419.14M | -$345.06M | -$397.05M | -1.07 | |||
 SYNASynaptics | $959.40M | $59.04 | -$1.61 | arrow_drop_down2.65% | - | $422.50M | -$75.80M | $125.60M | $99.80M | 4.28 | |||
 SMARSmartsheet | $958.33M | $56.47 | $0.03 | arrow_drop_up0.06% | arrow_drop_up24.96% | $771.89M | -$120.28M | -$104.63M | $3.25T | -0.07 | |||
ACADACADIA Pharmaceuticals | $957.79M | $21.83 | $0.22 | arrow_drop_up1.04% | arrow_drop_up31.84% | $875.95M | $230.79M | $226.45M | $100.16M | 1.36 | |||
HOPEHope Bancorp | $953.98M | $10.00 | -$0.06 | arrow_drop_down0.64% | arrow_drop_up66.94% | $953.98M | $945.01M | $99.63M | $0.00 | 0.82 | |||
BCPCBalchem | $953.68M | $166.39 | -$1.21 | arrow_drop_down0.72% | arrow_drop_up3.38% | $336.20M | $182.90M | $128.47M | $230.95M | 3.93 | |||
INSWInternational Seaways | $951.61M | $37.31 | $0.81 | arrow_drop_up2.22% | - | $627.60M | $455.22M | $416.72M | $583.38M | 8.38 | |||
NOVTNovanta | $949.24M | $120.06 | -$1.87 | arrow_drop_down1.53% | arrow_drop_up7.66% | $421.54M | $110.58M | $64.08M | $193.15M | 1.76 | |||
FRMEPFirst Merchants Corporation - Depository Shares, each representing a 1/100th interest in a share of 7.50% Non-Cumulative Perpetual Preferred Stock, A | $948.00M | $25.34 | -$0.13 | arrow_drop_down0.51% | arrow_drop_up45.62% | $948.00M | $940.61M | $201.40M | $0.00 | 3.81 | |||
FRMEFirst Merchants | $948.00M | $37.37 | -$0.12 | arrow_drop_down0.31% | arrow_drop_up45.62% | $948.00M | $940.61M | $201.40M | $0.00 | 3.41 | |||
CCCSCCC Intelligent Solutions Holdings | $944.80M | $8.47 | -$0.25 | arrow_drop_down2.89% | arrow_drop_up9.05% | $713.80M | $80.10M | $26.14M | $216.28M | 0.04 | |||
TNDMTandem Diabetes Care | $940.20M | $20.65 | -$0.07 | arrow_drop_down0.33% | arrow_drop_up25.74% | $489.57M | -$99.12M | -$96.02M | -$82.52M | -1.47 | |||
ALRMAlarm.com Holdings | $939.82M | $56.65 | -$0.19 | arrow_drop_down0.33% | arrow_drop_up6.59% | $613.67M | $108.54M | $122.51M | $196.29M | 2.29 |
Showing 1041-1060 of 4978
Results per page:
Gain deeper insights into a company's earnings with the Stocklytics Income Statement Screener, designed to rank stocks in descending order of revenue. This tool allows you to quickly assess companies with the highest revenue and their overall income performance, providing key financial metrics for smarter investment decisions.
Our screener offers detailed insights into the following income statement components:
- Revenue Growth – Identify companies with impressive year-over-year growth, a critical indicator of potential future success.
- Gross Profit – Analyze how well a company is managing its core production costs to generate profit.
- Operating Income – Understand a company’s ability to generate profit from its primary operations, excluding non-operational activities.
- Net Income – Examine the company's bottom line after all expenses, providing a clear picture of profitability.
- EBITDA – Evaluate a company’s earnings before interest, taxes, depreciation, and amortization to get a sense of its overall profitability and operating performance.
- EPS Diluted – Review earnings per share on a diluted basis, reflecting potential impacts of convertible securities and giving you a clearer picture of shareholder returns.
By using the Stocklytics Income Statement Screener, you’ll have access to vital financial data that will help you evaluate a company's performance, profitability, and growth potential.
Why the Income Statement Matters:
- Revenue Performance: Understand which companies are excelling at generating top-line revenue.
- Profitability: Analyze margins and earnings to identify financially strong companies.
- Earnings Per Share: Evaluate companies with high earnings per share, a key metric for investors.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools